# PRostate Cancer Individual Signature Evaluation Trial in Patients Undergoing Scheduled Prostate Biopsy

> **NCT00966095** · — · UNKNOWN · sponsor: **Source MDx** · enrollment: 1200 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00966095
- **Lead sponsor:** Source MDx
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2010-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00966095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00966095, "PRostate Cancer Individual Signature Evaluation Trial in Patients Undergoing Scheduled Prostate Biopsy". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00966095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*